4.7 Article

Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma

期刊

BRITISH JOURNAL OF CANCER
卷 109, 期 8, 页码 2266-2278

出版社

SPRINGERNATURE
DOI: 10.1038/bjc.2013.548

关键词

long non-coding RNAs; HOTAIR; epigenetic; oesophageal squamous cell carcinoma; metastasis; prognosis

类别

资金

  1. National Natural Science Foundation of China [31201033, 31270820, 81230061, 81121004]
  2. National Basic Science and Development Programme of China [2012CB518103, 2010CB912802]

向作者/读者索取更多资源

Background: HOX transcript antisense RNA (HOTAIR), which is expressed from the homebox C gene (HOXC) locus, is capable of reprogramming chromatin organisation and promoting cancer cell metastasis and can simultaneously bind the polycomb repressive complex 2, which enhances H3K27 trimethylation, and the LSD1-CoREST-REST complex, which is critical for H3K4 demethylation. Clinically, the overexpression of HOTAIR is a powerful predictor of the tumour progression and overall survival in patients with diverse cancers. The relationship between HOTAIR and oesophageal squamous cell carcinoma (ESCC), however, remains unclear. We investigated the role of HOTAIR in the pathogenesis of ESCC. Methods: We used quantitative real-time PCR to determine the level of HOTAIR in ESCC cell lines and 100 ESCC samples from patients; 56 adjacent non-neoplastic tissues were used as controls. We measured the effect of HOTAIR knockdown and overexpression in ESCC cell lines using colony formation assays, anchorage-independent growth assays, the CCK-8 assay, transwell migration and invasion assays, and Annexin V-binding assays. We analysed the growth of ESCC xenograft tumours in nude mice. Changes in the gene expression and methylation levels in ESCC cell lines were analysed using gene expression microarrays and the Infinium HumanMethylation450K BeadChip assay, respectively. Results: The levels of HOTAIR were increased in ESCC cell lines and patient samples compared with the controls; the expression levels correlated with the disease stage and survival time. The knockdown of HOTAIR in the KYSE510 and KYSE180 ESCC cell lines using small hairpin RNAs (shRNAs) reduced the ability of the cells to form foci, migrate, and invade the extracellular matrix in culture, altered cell cycle progression, and increased the sensitivity of the cells to apoptosis. The HOTAIR knockdown reduced cancer cell metastasis in vivo, and the tumours formed by HOTAIR-silenced ESCC cells were smaller, both in size and weight, than the tumours and metastases formed by the shRNA vector control cells in a mouse xenograft model. The results of the gene microarray study showed that HOTAIR reprogrammed the gene expression profile of ESCC cells, and the gene ontology analysis revealed an enrichment in genes that are important for tumorigenesis, such as genes involved in cell migration and the regulation of the cell cycle. Comparing the gene expression profiles and DNA methylation analysis between the KYSE180 and KYSE180_HOTAIR cells revealed that only a small proportion of the methylation changes were correlated with gene expression changes. Conclusion: HOX transcript antisense RNA is upregulated in ESCC cell lines and patient samples, and promotes ESCC cell proliferation and tumour metastasis in mice. The knockdown of HOTAIR resulted in significant changes in gene expression, and data analysis suggested that HOTAIR-mediated gene regulation has a critical role in ESCC progression and is a novel epigenetic molecular target for treating ESCC patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1-2 trial

Yajing Zhang, Yao Wang, Yang Liu, Chuan Tong, Chunmeng Wang, Yelei Guo, Dongdong Ti, Qingming Yang, Shen Qiao, Zhiqiang Wu, Weidong Han

Summary: A clinical trial of CAR T cell therapy for recurrent/refractory non-Hodgkin lymphoma showed a high overall response rate and progression-free survival, with manageable side effects such as cytokine release syndrome and CAR T cell-related encephalopathy syndrome.

LEUKEMIA (2022)

Review Biochemistry & Molecular Biology

Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease

Cheng Zhu, Qian Huai, Xu Zhang, Hanren Dai, Xiaolei Li, Hua Wang

Summary: This review summarizes the multiple roles of ceramides in the onset of fatty liver disease and the pathogenic mechanisms underlying their effects, and also discusses recent advances and challenges in pharmacological interventions targeting ceramide metabolism for the treatment of NAFLD.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2023)

Review Medicine, General & Internal

Challenges and optimal strategies of CAR T therapy for hematological malignancies

Yajing Zhang, Yang Xu, Xiuyong Dang, Zeyu Zhu, Wenbin Qian, Aibin Liang, Weidong Han

Summary: The remarkable improvement of CAR-T cell therapy in the treatment of hematological malignancies relative to traditional approaches has led to the sequential approvals of eight commercial CAR-T products in the past five years. While the productization of CAR-T cells is rapidly expanding their clinical application in real-world patients, the limitations of their clinical efficacy and associated toxicities inspire the further optimization of CAR structure and substantial development of innovative trials. This article summarizes the current status and major progress of CAR-T therapy for hematological malignancies, discusses the factors that may compromise the clinical efficacy of CAR-T cells, such as CAR-T cell exhaustion and loss of antigen, and proposes potential optimization strategies to address the challenges in the field of CAR-T therapy.

CHINESE MEDICAL JOURNAL (2023)

Article Biochemistry & Molecular Biology

Epigenetic reprogramming of Runx3 reinforces CD8+T-cell function and improves the clinical response to immunotherapy

Zongzhi Liu, Xiang Li, Yibo Gao, Jiejie Liu, Yating Feng, Yang Liu, Junyun Wang, Chunmeng Wang, Dongrui Wang, Jie He, Weidong Han, Qian Mei, Yingli Sun

Summary: The combination of low-dose decitabine and PD-1 antibody treatment improves the complete response rate of cHL patients, indicating the correlation between epigenetic regulation and the clinical response to immunotherapy.

MOLECULAR CANCER (2023)

Article Oncology

2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma

Ping Li, Yang Liu, Yun Liang, Jian Bo, Sujun Gao, Yongxian Hu, Yu Hu, He Huang, Xiaojun Huang, Hongmei Jing, Xiaoyan Ke, Jianyong Li, Yuhua Li, Qifa Liu, Peihua Lu, Heng Mei, Ting Niu, Yongping Song, Yuqin Song, Liping Su, Sanfang Tu, Jianxiang Wang, Depei Wu, Zhao Wang, Kailin Xu, Zhitao Ying, Qingming Yang, Yajing Zhang, Fengxia Shi, Bin Zhang, Huilai Zhang, Xi Zhang, Mingfeng Zhao, Weili Zhao, Xiangyu Zhao, Liang Huang, Jun Zhu, Wenbin Qian, Weidong Han, Aibin Liang

Summary: Adoptive cellular immunotherapy with CAR T cells is a promising approach for treating relapsed and/or refractory B-NHL. However, CAR T-cell-associated toxicities can be severe, compromising the survival benefit. Clinical management of these toxicities is crucial, but previous guidelines provide limited recommendations.

CANCER BIOLOGY & MEDICINE (2023)

Article Biology

Nitric oxide-dependent immunosuppressive function of thymus-derived mesenchymal stromal/stem cells

Xiao Su, Xiaolei Li, Shiqing Wang, Xiaotong Xue, Rui Liu, Xiaojing Bai, Pixia Gong, Chao Feng, Lijuan Cao, Tingting Wang, Yayun Ding, Junjie Jiang, Yongjing Chen, Yufang Shi, Changshun Shao

Summary: This study found that Nestin-positive mesenchymal stromal cells (T-MSCs) mainly distribute in the medulla and cortical-medulla junction of the thymus, and possess immunosuppressive ability. Additionally, T-MSCs exhibit remarkable therapeutic efficacy in acute liver injury and inflammatory bowel disease (IBD).

BIOLOGY DIRECT (2023)

Article Immunology

IL-6 translation is a therapeutic target of human cytokine release syndrome

Yuzhuo Yang, Yajing Zhang, Xiaoyan Xing, Gang Xu, Xin Lin, Yao Wang, Meixia Chen, Chunmeng Wang, Bin Zhang, Weidong Han, Xiaoyu Hu

Summary: Metoprolol, an FDA-approved drug for cardiovascular conditions, may alleviate cytokine release syndrome (CRS) caused by CAR T-cell therapy. It was found that metoprolol blocks IL-6 protein translation rather than IL-6 mRNA expression. Clinical trials have shown that metoprolol has a favorable safety profile in CRS management and does not compromise the efficacy of CAR T-cell therapy.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Obstetrics & Gynecology

The Identification of Gamma-Glutamyl Hydrolase in Uterine Corpus Endometrial Carcinoma: a Predictive Model and Machine Learning

Cheng Zhu, Yishan Du, Qian Huai, Nana Fang, Wentao Xu, Jing Yang, Xingyu Li, Yanyan Zhang, Xu Zhang, Hanren Dai, Xiaolei Li, Hua Wang, Ying Dai

Summary: The study identifies gamma-glutamyl hydrolase (GGH) as a candidate gene that may influence the progression of uterine corpus endometrial carcinoma (UCEC) by regulating the glycolytic process and is closely associated with various immune cell infiltrations. GGH plays a significant role in the prognosis of UCEC.

REPRODUCTIVE SCIENCES (2023)

Review Biochemistry & Molecular Biology

Mesenchymal stromal/stem cells and their extracellular vesicles in liver diseases: insights on their immunomodulatory roles and clinical applications

Qian Huai, Cheng Zhu, Xu Zhang, Hanren Dai, Xiaolei Li, Hua Wang

Summary: Liver disease is a major global cause of death and disability. Chronic liver inflammation and fibrosis can result from various insults, leading to irreversible dysfunction. Liver transplantation is currently the last resort for end-stage liver disease, but faces challenges. Mesenchymal stromal/stem cells (MSCs) offer a promising alternative with anti-inflammatory and immunomodulatory properties. This review discusses the characteristics of MSCs and their potential mechanism in liver disease treatment, as well as strategies to enhance their therapeutic properties. The clinical application of MSCs and their extracellular vesicles in liver diseases is also explored.

CELL AND BIOSCIENCE (2023)

Letter Oncology

Development of immune-related cell-based machine learning for disease progression and prognosis of alcoholic liver disease

Xu Zhang, Xuezhe Feng, Qian Huai, Cheng Zhu, Yingyin Sun, Xiaolei Li, Hanren Dai, Honglin Wang, Hua Wang

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Characteristics of premanufacture CD8+T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma

Yao Wang, Chuan Tong, Yuting Lu, Zhiqiang Wu, Yelei Guo, Yang Liu, Jianshu Wei, Chunmeng Wang, Qingming Yang, Weidong Han

Summary: CAR-T cell therapy has become an important treatment option for patients with relapsed/refractory B-cell malignancies, but a significant number of DLBCL patients fail to achieve durable response. This study analyzed the characteristics of pre-manufacture T cells and CAR-T cell products in DLBCL patients and identified the key role of CD8+ stem cell-like memory T cells in achieving durable clinical response. Heterogeneity in the cellular and molecular features of pre-manufacture T cells contributes to the variation in efficacy after CAR-T cell therapy, and loss of CCR7 gene expression and increased expression of activation- and inhibitor-related genes in CD8+ naive-T cell populations may explain the differences in anti-tumor efficacy among patients with different clinical outcomes.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Article Gastroenterology & Hepatology

GDF15 Ameliorates Liver Fibrosis by Metabolic Reprogramming of Macrophages to Acquire Anti-Inflammatory Properties

Xiaolei Li, Qian Huai, Cheng Zhu, Xu Zhang, Wentao Xu, Hanren Dai, Hua Wang

Summary: GDF15 plays an immunomodulatory role in liver fibrosis and has therapeutic potential. It improves liver fibrosis by modulating liver macrophages and can acquire an anti-inflammatory function by reprogramming macrophage metabolic pathways.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies

Xin Yan, Deyun Chen, Yao Wang, Yelei Guo, Chuan Tong, Jianshu Wei, Yajing Zhang, Zhiqiang Wu, Weidong Han

Summary: Loss of NOXA, a BCL2 family protein, was identified as a key regulator of resistance to CAR T-cell therapy. Low NOXA expression was associated with worse survival in patients with B-cell lymphoma. In vitro and in vivo experiments showed that enhancing NOXA expression using HDAC inhibitors dramatically increased sensitivity of cancer cells to CAR T-cell clearance.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Oncology

Inducing immunogenic cell death in immuno-oncological therapies

Dongdong Ti, Xin Yan, Jianshu Wei, Zhiqiang Wu, Yao Wang, Weidong Han

Summary: Immunogenic cell death is a regulated form of cell death that activates immune responses in the tumor microenvironment, improving the efficacy of cancer treatment. Inducers of immunogenic cell death enhance the immunogenicity of cancer cells and modulate the tumor microenvironment, amplifying antitumor immune responses.

CHINESE JOURNAL OF CANCER RESEARCH (2022)

Article Oncology

Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer

Baolin Liu, Xueda Hu, Kaichao Feng, Ranran Gao, Zhiqiang Xue, Sujie Zhang, Yuanyuan Zhang, Emily Corse, Yi Hu, Weidong Han, Zemin Zhang

Summary: In lung cancer patients treated with anti-PD-1, precursor exhausted T cells were found in responders, accumulating through local expansion and clonal revival from peripheral T cells.

NATURE CANCER (2022)

暂无数据